PainChek logo
PCKPainChek
Trade PCK now
PainChek primary media

About PainChek

PainChek (ASX:PCK) is a digital health company that has developed a proprietary AI-powered technology to remotely monitor and assess pain in patients of all ages. The company's flagship product, PainChek Universal, is a non-invasive medical device that uses facial recognition and machine learning to identify and measure pain in real time. PainChek Universal is used in a variety of settings, including hospitals, aged care facilities, and homes. The device is particularly useful for patients who are unable to communicate their pain verbally, such as infants, people with dementia, and people with disabilities.

What is PCK known for?

Snapshot

Public AU
Ownership
2010
Year founded
33
Employees
New South Wales, Australia
Head office
1 of 527
AU Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
Australia

Products and/or services of PainChek

  • PainChek® Universal: a digital pain assessment tool utilising AI and facial recognition technology.
  • Addressing Communication Gaps: Provides objective pain assessment for individuals unable to communicate effectively, including those with dementia, disabilities, or language barriers.
  • Improving Care Decisions: Empowers healthcare professionals with accurate and timely pain data to optimise treatment plans and medication dosing.
  • Boosting Patient Outcomes: Reduces under- and over-treatment of pain, leading to improved quality of life and reduced medication-related side effects.
  • Globally Recognized: Operates in Australia, Europe, and other regions, with regulatory approvals and distribution partnerships secured.
  • Committed to Innovation: Continuously developing new features and integrations for PainChek® to enhance its clinical utility and reach, ultimately aiming to improve pain management for all.

PainChek executive team

  • Mr. Philip Daffas B.Sc., Dip EENG, GAICD, M.B.A.MD, CEO & Director
  • Mr. Iain McAdamChief Financial Officer
  • Mr. Andrew HogganManager & Head of Operations
  • Mr. Scott Robertson M.B.A.Chief Technology Officer
  • Prof. Jeff Hughes Ph.D.Chief Scientific Officer
  • Mr. David AllsoppHead of Business Development of North America
  • Mr. Nick GarofoliHead of Business Development of USA
  • Ms. Sasha GrantHead of Growth for PainChek Infant App
  • Ms. Natalie Sylvia Climo L.L.B.Company Secretary

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.